Henkel AG & Co KGaA (HELKF) reports robust financial performance with a 25% EPS increase and announces a significant share ...

While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...

Kepler Capital analyst Christian Faitz maintained a Buy rating on Henkel AG & Co. KGaA (0IZC – Research Report) on March 11 and set a ...

In a report released on March 11, Craig Abbott from Kepler Capital maintained a Buy rating on Stroeer SE & Co. KGaA (0MYZ – Research ...

Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence ...

Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly looking forward to any comments about its ...

Phenom today unveiled the winners of its 2025 Talent Experience awards. The awards celebrate the extraordinary achievements ...

One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...

Chinese automotive interiors supplier Ningbo Huaxiang Electronic Co. has agreed to unload its loss-making European unit, NBHX ...

Merck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...